Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SiBone (SIBN : NSDQ)

• Company Description    SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. Number of Employees: 349

• Price / Volume Information    Yesterday's Closing Price: $15.70 Daily Weekly Monthly 20 Day Moving Average: 309,629 shares Shares Outstanding: 43.14 (millions) Market Capitalization: $677.31 (millions) Beta: 0.81 52 Week High: $20.05 52 Week Low: $11.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.61% 0.81% 12 Week -5.88% -14.50% Year To Date 11.98% 3.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 471 EL CAMINO REAL SUITE 101 - SANTA CLARA,CA 95050 USA ph: 408-207-0700 fax: - investors@si-bone.com http://si-bone.com

• General Corporate Information    Officers Laura A. Francis - Chief Executive Officer Jeffrey W. Dunn - Chairman Anshul Maheshwari - Chief Financial Officer John G. Freund - Director Jeryl L. Hilleman - Director Peer Information SiBone (ABMD) SiBone (DMDS) SiBone (CPWY.) SiBone (EQUR) SiBone (ECIA) SiBone (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 825704109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 43.14 Most Recent Split Date: (:1) Beta: 0.81 Market Capitalization: $677.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.93 Price/Cash Flow: - Price / Sales: 3.66 EPS Growth vs. Year Ago Period: 36.36% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: 21.67% vs. Previous Quarter: 2.83% ROE 06/30/25 - -14.20 03/31/25 - -16.00 12/31/24 - -18.67 ROA 06/30/25 - -10.38 03/31/25 - -11.69 12/31/24 - -13.66 Current Ratio 06/30/25 - 8.38 03/31/25 - 8.53 12/31/24 - 7.66 Quick Ratio 06/30/25 - 7.00 03/31/25 - 7.26 12/31/24 - 6.66 Operating Margin 06/30/25 - -12.83 03/31/25 - -15.03 12/31/24 - -18.49 Net Margin 06/30/25 - -12.83 03/31/25 - -15.03 12/31/24 - -18.49 Pre-Tax Margin 06/30/25 - -12.83 03/31/25 - -15.03 12/31/24 - -18.49 Book Value 06/30/25 - 4.00 03/31/25 - 3.93 12/31/24 - 3.98 Inventory Turnover 06/30/25 - 1.30 03/31/25 - 1.38 12/31/24 - 1.45 Debt-to-Equity 06/30/25 - 0.21 03/31/25 - 0.21 12/31/24 - 0.21 Debt-to-Capital 06/30/25 - 17.25 03/31/25 - 17.50 12/31/24 - 17.51

Powered by Zacks Investment Research ©